Premier Alternatives

Pathos AI

Chicago, IL · Founded 2020 · Privately Held (backing)

Developer of a drug discovery platform designed to reduce the duration of the medication development process. Pathos AI is based in Chicago, IL and was founded in 2020. It was valued at $1.6 billion at its later-stage round in May 2025, the last priced event on record. It has raised $467 million across 3 recorded rounds; the latest was a $283 million later-stage round in Apr 2025.

PMV mark · valuation
$1.6B
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$467.0M
Last round
Later Stage VC
Apr 2025

Pathos AI key facts

as of Oct 2026
  • Developer of a drug discovery platform designed to reduce the duration of the medication development process.
  • Pathos AI is valued at approximately $1.6B as of Oct 2026, set at its later-stage round, May 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $467.0M across 3 recorded rounds; the latest was Later Stage VC ($283.0M) in Apr 2025.
  • Notable investors include New Enterprise Associates, Builders VC, Lightbank (Venture Capital), Eric Lefkofsky, Revolution (Washington DC).
  • Pathos AI has filed 3 Form Ds with the SEC since 2023, most recently May 2025 ($283.0M sold to 11 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$1.6B

Valued at $1.6B at its later-stage round, May 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Pathos AI with a free account
  • ·Watch Pathos AI: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Pathos AI funding rounds

3 rounds
Apr 2025Later Stage VC$283.0MSEC filing▮
Oct 2024Later Stage VC$62.0MSEC filing▮
Feb 2023Early Stage VC$20.0MSEC filing▮
Full funding history →

Pathos AI valuation

Pathos AI was valued at $1.6 billion at its later-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Pathos AI raised?

Pathos AI has raised $467 million across 3 recorded rounds since 2023. The largest was a $62 million later-stage round in Oct 2024; the most recent was a $283 million later-stage round in Apr 2025.

Pathos AI has filed 3 Form Ds with the SEC since 2023, most recently in May 2025 ($283 million sold to 11 investors).

Pathos AI investors

5 investors are on record for Pathos AI, including New Enterprise Associates, Builders VC, Lightbank (Venture Capital) and Eric Lefkofsky. The later-stage round in Apr 2025 drew 11 investors.

About Pathos AI

Developer of a drug discovery platform designed to reduce the duration of the medication development process. The company's self-learning platform uses big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy, enabling drug developers to explore novel concepts and advance breakthrough therapies for cancer and other diseases.

Sector
Healthcare
HQ
Chicago, IL, United States
Founded
2020
Employees
85
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.